Spurr Robert
U.S. President-Pharma Business at BHC
- Sold, on record
- $348k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Apr 14, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BHCBausch Health Companies Inc.U.S. President-Pharma Business
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BHCPlan not statedJan 18, 2022 2022
Sold 3,251 shares at $26.63 ($87k)
Spurr Robert, U.S. President-Pharma Business
Sold 4.9% of holdings ($1.8M position)63,550 shares leftFirst sale on recordFiling
- 2 Form 4 sale BHCPlan not statedFeb 15, 2022 +28 days
Sold 3,251 shares at $25.02 ($81k)
Spurr Robert, U.S. President-Pharma Business
Sold 5.1% of holdings ($1.6M position)60,299 shares leftFiling
- 3 Form 4 sale BHCPlan not statedMar 2, 2022 +15 days
Sold 1,595 shares at $23.37 ($37k)
Spurr Robert, U.S. President-Pharma Business
Sold 2.4% of holdings ($1.6M position)65,394 shares leftFiling
- 4 Form 4 sale BHCPlan not statedMar 15, 2022 +13 days
Sold 4,846 shares at $22.20 ($108k)
Spurr Robert, U.S. President-Pharma Business
Sold 5% of holdings ($2.2M position)92,101 shares left1.5x usual sizeFiling
- 5 Form 4 sale BHCPlan not statedApr 14, 2022 +30 days
Sold 1,595 shares at $22.19 ($35k)
Spurr Robert, U.S. President-Pharma Business
Sold 1.7% of holdings ($2M position)90,506 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Apr 15, 2022 | BHC | U.S. President-Pharma Business | Form 4 sale | 1,595 | $35k | 1.7% | Plan not stated | SEC |
| Mar 15, 2022 | Mar 16, 2022 | BHC | U.S. President-Pharma Business | Form 4 sale | 4,846 | $108k | 5.0% | Plan not stated | SEC |
| Mar 2, 2022 | Mar 4, 2022 | BHC | U.S. President-Pharma Business | Form 4 sale | 1,595 | $37k | 2.4% | Plan not stated | SEC |
| Feb 15, 2022 | Feb 17, 2022 | BHC | U.S. President-Pharma Business | Form 4 sale | 3,251 | $81k | 5.1% | Plan not stated | SEC |
| Jan 18, 2022 | Jan 20, 2022 | BHC | U.S. President-Pharma Business | Form 4 sale | 3,251 | $87k | 4.9% | Plan not stated | SEC |